Growth-Hormone & Body-Composition Research
Ipamorelin 10mg

Ipamorelin 10mg
A focused lens on selective GH-release signalling.
A selective ghrelin-receptor agonist studied for controlled growth-hormone release and secretagogue pharmacology.
- Documentation
- Check batch record
- Availability
- In stock
For qualified laboratory research only · Not for human or veterinary use
Why researchers choose it
Ipamorelin activates the growth-hormone secretagogue receptor. Early human pharmacology recorded a discrete, dose-linked GH response, making the molecule relevant to selective secretagogue research.
Research focus
- Ghrelin-receptor agonism
- Selective growth-hormone release
- Secretagogue PK and PD research
Evidence snapshot
Early human studies support short-term pharmacodynamic GH release, not physique, strength, fat-loss or recovery outcomes. Product-specific human safety is not established.
Best suited to
For controlled secretagogue and endocrine-response research with defined sampling windows.
Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.
Related research compounds
GH & Body CompositionA long-acting GHRH analogue studied for sustained growth-hormone and IGF-1 signalling in endocrine research.
GH & Body Composition10mg
A GHRF analogue studied across growth-hormone signalling, IGF-1 response and visceral-adipose biology.
